COYA vs IP · rev $7.9M vs P/E 43, rev $6.01B
Coya Therapeutics, Inc. Common Stock (COYA) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
Latest reported IP revenue for 2025-12-31 was $6.01B. Net income was -$2.38B. Revenue was up 53.1% from 2024-12-31 to 2025-12-31. IP currently screens at market cap $26.62B and trailing P/E 43.1.
COYA currently screens at market cap $118.0M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the COYA and IP stock pages for the full models.
Not investment advice.